.webp)
Ozempic® (semaglutide) has become one of the most prescribed weight-loss drugs in the U.S., originally developed for type 2 diabetes but now widely used for obesity. The promise is simple: weekly injections that suppress appetite, slow digestion, and lead to weight loss.
For many, the first months are exciting — smaller portions, quick weight loss, and hope after years of failed diets. But long-term stories are painting a more complicated picture.
According to the manufacturer, the most frequent side effects involve digestion:
These are most likely to occur when starting or increasing the dose. Doctors recommend small, bland meals and hydration to help manage symptoms.
Patients and clinicians are reporting symptoms not always discussed at the start:
While some may be linked to rapid weight loss and nutrient deficiencies, these changes can feel alarming, especially with long-term use.
A key issue with Ozempic is what happens when you stop. Studies and patient reports show:
In many cases, doctors recommend indefinite use to maintain results. For patients, that can mean years of injections, expense, and uncertainty about long-term safety.
While Ozempic is relatively new in weight management, bariatric surgery has decades of data showing durable results.
Ozempic can help some patients in the short term, but the long-term unknowns and rebound effect raise serious concerns. Bariatric surgery, while more invasive up front, is proven to help patients achieve lasting weight loss, better health, and improved quality of life.
At BASS Bariatric Surgery Center, we’ve performed over 2,000 successful procedures with lower-than-average complication rates. Our experienced team provides ongoing care to help you succeed for life.
Call us at (925) 940-1052 or request a consultation online today.